Hikal Ltd successfully completes ANVISA GMP audit of Jigani unit

Hikal Ltd has successfully passed the Brazilian Health Regulatory Agency's (ANVISA) GMP audit for its manufacturing unit located at Jigani in Bengaluru, Karnataka. The inspection, carried out by ANVISA, Brazil GMP (Good Manufacturing Practices), was for multiple API's which occurred from April 14th to April 18th, 2025.

Shares of Hikal Limited was last trading in BSE at Rs. 375.90 as compared to the previous close of Rs. 378.75. The total number of shares traded during the day was 8638 in over 365 trades.

The stock hit an intraday high of Rs. 378.00 and intraday low of 371.00. The net turnover during the day was Rs. 3235982.00.

Source : Equity Bulls

Keywords

Hikal INE475B01022 Pharmaceuticals ANVISA GMPAudit Jigani SuccessfulCompletion